Literature DB >> 35783032

Corrigendum for health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry.

J Minhas, S P Narasimmal, T M Bull, T De Marco, J W Mc Connell, M R Lammi, T Thenappan, J P Feldman, J S Sager, D B Badesch, J J Ryan, D C Grinnan, D Zwicke, E M Horn, J M Elwing, J E Moss, M Eggert, O A Shlobin, R P Frantz, S D Bartolome, S C Mathai, S Mazimba, S C Pugliese, N Al-Naamani.   

Abstract

[This corrects the article DOI: 10.1177/20458940211053196.].
© 2022 The Authors. Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute.

Entities:  

Year:  2022        PMID: 35783032      PMCID: PMC9236616          DOI: 10.1002/pul2.12085

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


The Pulmonary Hypertension Association Registry (PHAR) became aware of an error in coding of one of the quality of life metrics, the SF‐12. The coding error affected both the mental and physical SF‐12 component scores. The PHAR provided the authors (J. Minhas et al.) with an updated data set and the authors performed their analysis on the updated data set. The PHAR and authors (J. Minhas et al.) apologize for the error and state that this does not change the scientific conclusions of the article in any way. The SF‐12 scores in Table 1 (last two rows) should be corrected to SF‐12 physical component score for IPAH = 35 ± 11 and for CTEPH = 35 ± 11 whereas the SF‐12 mental component score for IPAH = 48 ± 11 and for CTEPH = 47 ± 11. The SF‐12 scores in table 2 (last two rows) should be corrected to SF‐12 physical component score for Medical management = 34 ± 10 and for PTE = 39 ± 10 whereas the SF‐12 mental component score for Medical management = 49 ± 11 and for PTE = 50 ± 12. Table 2 have been corrected. Corrected Figures 2, 3, and 6 have been updated.
FIGURE 2

FIGURE 3

FIGURE 6

  1 in total

1.  On errata and corrigenda-The Pulmonary Hypertension Association Registry (PHAR).

Authors:  Kayleen Williams; Noah A Kime; Richard A Kronmal; Nadine Al-Naamani
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.